Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Army
Boehringer Ingelheim
Mallinckrodt
Fuji
Teva
US Department of Justice
Harvard Business School
Healthtrust

Generated: September 26, 2018

DrugPatentWatch Database Preview

Testosterone undecanoate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for testosterone undecanoate and what is the scope of testosterone undecanoate freedom to operate?

Testosterone undecanoate is the generic ingredient in one branded drug marketed by Endo Pharms Inc and is included in one NDA. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are sixty-five drug master file entries for testosterone undecanoate. One supplier is listed for this compound.

Pharmacology for testosterone undecanoate
Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Synonyms for testosterone undecanoate
(17-beta)-3-Oxoandrost-4-en-17-yl undecanoate
(17|A)-17-[(1-| xoundecyl)oxy]androst-4-en-3-one
(17beta)-3-Oxoandrost-4-en-17-yl undecanoate
(1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl undecanoate
(1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0?,?.0??,??]heptadec-6-en-14-yl undecanoate
(1S,2R,10R,11S,14S,15S)-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL UNDECANOATE
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate
17beta-Hydroxyandrost-4-en-3-one undecanoate
3-Oxoandrost-4-en-17beta-yl undecanoate
4-08-00-00981 (Beilstein Handbook Reference)
5-.alpha.-Androstan-3-one, 17-.beta.-hydroxy-, undecanoate
5-alpha-Androstan-3-one, 17-beta-hydroxy-, undecanoate
5949-44-0
949T440
AC1L22PV
AK115043
AKOS016010255
Ambotz105300-28-5
AN-11881
Andriol
Andriol (TN)
Andriol Testocaps
Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17-beta)-
Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17beta)-
Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-(17beta)
Androst-4-en-3-one, 17-[(1-oxoundecyl)oxy]-, (17.beta.)-
BAY 86-5037
BRN 3176734
C-22555
CC-34823
CHEBI:135741
CHEMBL2107067
CLR-610
CS-4342
D02AXG
D06087
EINECS 227-712-6
GS-6598
H16A5VCT9C
HY-B0626
Jatenzo
LP095070
LS-148824
MFCD00468114
MolPort-003-850-422
Nebido
Nebido-R
Org 538
ORG-538
Pantestone
PL000411
Reandron 1000
Restandol
Restandol (TN)
Rextoro
SC-16124
SCHEMBL147620
T undecanoate
Testosterone (undecanoate)
Testosterone undecanoate (USAN)
Testosterone undecanoate [USAN]
Testosterone Undeconate
Testosterone undecylate
Testosterone, undecanoate
Testosterone, undecanoate (ester)
Testosteroneundecanoate
Testrosterone undecanoate
UDSFVOAUHKGBEK-CNQKSJKFSA-N
Undestor
UNII-H16A5VCT9C
W-105318
ZINC8214690

US Patents and Regulatory Information for testosterone undecanoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms Inc AVEED testosterone undecanoate INJECTABLE;INTRAMUSCULAR 022219-001 Mar 5, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms Inc AVEED testosterone undecanoate INJECTABLE;INTRAMUSCULAR 022219-001 Mar 5, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for testosterone undecanoate

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Army
Boehringer Ingelheim
Mallinckrodt
Fuji
Teva
US Department of Justice
Harvard Business School
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.